By Think Advisor
Emerging markets often disappoint, but the market has evolved in a number of important ways, GMO analysts say.
For years, emerging market equities have been favored by many strategists for their strong potential growth and relatively cheap prices compared to developed market equities, but they frequently disappoint.
Even last year when the MSCI Emerging Markets Index climbed 18.4%, the S&P 500 gained over 60% more, up 30%.
This year, however, could be different.